Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000116930 | SCV000523004 | benign | not specified | 2016-05-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000549464 | SCV000649693 | benign | Qualitative or quantitative defects of dysferlin | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV004584606 | SCV005074647 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | DYSF: BS1, BS2 |
Breakthrough Genomics, |
RCV004584606 | SCV005240222 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000116930 | SCV000151031 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Natera, |
RCV001271540 | SCV001452773 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2020-09-16 | no assertion criteria provided | clinical testing |